GMP Testing Service Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

The global GMP Testing Service market is set to witness substantial growth over the next decade, driven by factors such as the burgeoning pharmaceutical sector and heightened activity in medication and medical device development. According to recent data, the market was valued at US$ 2 Billion in 2024 and is reaching a valuation of US$ 3 Billion by the end of 2031.

Meeting Quality Standards through GMP Testing Services

GMP testing services play a pivotal role in ensuring the quality, safety, purity, and efficacy of pharmaceuticals and medical devices distributed to the public. These services encompass a wide range of offerings, including bioanalytical testing, product development testing, sterility testing, and shelf-life testing. Their importance cannot be overstated, particularly in the production of innovative specialty pharmaceuticals, where precision and quality are paramount to meet certification standards.

Driving Growth: The Medical Device Sector

One key driver shaping the growth potential of the GMP Testing Service market is the burgeoning medical device sector. This sector continuously develops cutting-edge medical technologies used for the diagnosis and treatment of various medical conditions. From insulin delivery systems to oxygen concentrators, these devices are increasingly utilized at home and are interconnected with electronic medical records, wearables, smartphones, and telemedicine platforms to provide crucial data for improved clinical and operational decisions.

Challenges in Regulatory Compliance

Despite the promising growth prospects, the lack of a unified regulatory framework for GMP testing services remains a hurdle to industry growth. Regulatory compliance standards are often determined by the geographical reach of pharmaceutical and biotechnology companies' distribution networks. Entities such as the FDA, EMA, ASEAN, and the Pharmaceutical Inspection Convention oversee GMP testing services, depending on the location of production and distribution.

Regional Dynamics: Opportunities and Challenges

The GMP testing services market is geographically segmented into South Asia, East Asia, Europe, Latin America, North America, Oceania, and the Middle East and Africa. The WHO's version of GMP is widely adopted in underdeveloped nations, but each country may have its specific GMP criteria.

Investments in North America

North America is poised to be a dominant region in the GMP testing services market due to the increasing demand for innovative pharmaceuticals and technologies. Statistics from the Centers for Disease Control and Prevention reveal substantial healthcare needs in the region, with millions of Americans suffering from conditions such as diabetes and heart disease.

China's Evolving Market

China's growing number of contract manufacturing units is expected to drive demand for GMP testing services. These services are crucial to ensure compliance and quality standards are met in both the originating unit and the manufacturing unit where production is outsourced.

Competitive Landscape

The GMP Testing Service industry boasts several key players, with a few prominent firms currently dominating the market share. These companies are actively responding to the heightened demand for medications and medical devices, emphasizing quality control, and ensuring uniform testing settings for a successful production cycle.

Key Companies Profiled

Eurofins Scientific
North American Science Associates Inc.
Almac Group
PPD Inc.
Intertek Group PLC
Nelson Laboratories LLC
Wuxi AppTec.
Sartorius AG
Boston Analyticals
Pace Analyticals

Key Segments in GMP Testing Service Industry Research

By Type

Product Validation Testing
Bioanalytical Services
Packaging & Shelf-Life Testing
Other Services Type

By End User

Pharmaceutical and Biopharmaceutical Companies
Medical Device Companies

By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1. Executive Summary

1.1. Global GMP Testing Service Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global GMP Testing Service Market Outlook, 2018 - 2031

3.1. Global GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Product Validation Testing
  - 3.1.1.2. Bioanalytical Services
  - 3.1.1.3. Packaging & Shelf-Life Testing
  - 3.1.1.4. Other Services Type
3.2. Global GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Pharmaceutical and Biopharmaceutical Companies
  - 3.2.1.2. Medical Device Companies
3.3. Global GMP Testing Service Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America GMP Testing Service Market Outlook, 2018 - 2031

4.1. North America GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Product Validation Testing
  - 4.1.1.2. Bioanalytical Services
  - 4.1.1.3. Packaging & Shelf-Life Testing
  - 4.1.1.4. Other Services Type
4.2. North America GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Pharmaceutical and Biopharmaceutical Companies
  - 4.2.1.2. Medical Device Companies
- 4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe GMP Testing Service Market Outlook, 2018 - 2031

5.1. Europe GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Product Validation Testing
  - 5.1.1.2. Bioanalytical Services
  - 5.1.1.3. Packaging & Shelf-Life Testing
  - 5.1.1.4. Other Services Type
5.2. Europe GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Pharmaceutical and Biopharmaceutical Companies
  - 5.2.1.2. Medical Device Companies
- 5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific GMP Testing Service Market Outlook, 2018 - 2031

6.1. Asia Pacific GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Product Validation Testing
  - 6.1.1.2. Bioanalytical Services
  - 6.1.1.3. Packaging & Shelf-Life Testing
  - 6.1.1.4. Other Services Type
6.2. Asia Pacific GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Pharmaceutical and Biopharmaceutical Companies
  - 6.2.1.2. Medical Device Companies
- 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America GMP Testing Service Market Outlook, 2018 - 2031

7.1. Latin America GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Product Validation Testing
  - 7.1.1.2. Bioanalytical Services
  - 7.1.1.3. Packaging & Shelf-Life Testing
  - 7.1.1.4. Other Services Type
7.2. Latin America GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa GMP Testing Service Market Outlook, 2018 - 2031

8.1. Middle East & Africa GMP Testing Service Market Outlook, by Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Product Validation Testing
  - 8.1.1.2. Bioanalytical Services
  - 8.1.1.3. Packaging & Shelf-Life Testing
  - 8.1.1.4. Other Services Type
8.2. Middle East & Africa GMP Testing Service Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Pharmaceutical and Biopharmaceutical Companies
  - 8.2.1.2. Medical Device Companies
- 8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa GMP Testing Service Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa GMP Testing Service Market by Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa GMP Testing Service Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Eurofins Scientific
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. North American Science Associates Inc.
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Almac Group
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. PPD Inc.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Intertek Group PLC
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Nelson Laboratories LLC
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Wuxi AppTec.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. Sartorius AG
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Boston Analyticals
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Pace Analyticals
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations